Minor groove binders 1998-2004

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Several classes of compounds, including heterocyclic polyamides, aryl benzimidazoles, pyrrolobenzodiazepines, amidino arylfurans and benzofurans, have been found to bind to the minor groove of DNA with sequence selectivity and potential therapeutic consequences. Many such compounds are synthetic analogues of natural products such as distamycin, netropsin, CC-1065, duocarmycin and anthramycin. Biological activity has been demonstrated in antibacterial, antifungal, antiviral and anticancer applications, and several compounds are in clinical trials. This review covers patents since 1998 and reviews the structures, mechanisms and biological activity of minor groove binders in the context of the current scientific understanding described in the journal literature.
LanguageEnglish
Pages1693-1724
Number of pages31
JournalExpert Opinion on Therapeutic Patents
Volume14
Issue number12
DOIs
Publication statusPublished - 1 Dec 2004

Fingerprint

CC 1065
Anthramycin
Benzofurans
Netropsin
Benzimidazoles
Heterocyclic Compounds
Patents
Nylons
Biological Products
Antiviral Agents
Clinical Trials
Therapeutics
pyrrolo(2,1-c)(1,4)benzodiazepine
stallimycin

Keywords

  • antibacterial agent
  • antifungal agent
  • antiviral agent
  • aryl benzimidazole
  • cancer chemotherapy
  • DNA binding compound
  • heterocyclic polyamide
  • minor groove
  • natural product analogue
  • pyrrolobenzodiazepine

Cite this

@article{c311e6c8e781422387ec42cd17a3d7ab,
title = "Minor groove binders 1998-2004",
abstract = "Several classes of compounds, including heterocyclic polyamides, aryl benzimidazoles, pyrrolobenzodiazepines, amidino arylfurans and benzofurans, have been found to bind to the minor groove of DNA with sequence selectivity and potential therapeutic consequences. Many such compounds are synthetic analogues of natural products such as distamycin, netropsin, CC-1065, duocarmycin and anthramycin. Biological activity has been demonstrated in antibacterial, antifungal, antiviral and anticancer applications, and several compounds are in clinical trials. This review covers patents since 1998 and reviews the structures, mechanisms and biological activity of minor groove binders in the context of the current scientific understanding described in the journal literature.",
keywords = "antibacterial agent, antifungal agent, antiviral agent, aryl benzimidazole, cancer chemotherapy, DNA binding compound, heterocyclic polyamide, minor groove, natural product analogue, pyrrolobenzodiazepine",
author = "C.J. Suckling",
year = "2004",
month = "12",
day = "1",
doi = "10.1517/13543776.14.12.1693",
language = "English",
volume = "14",
pages = "1693--1724",
journal = "Expert Opinion on Therapeutic Patents",
issn = "1354-3776",
number = "12",

}

Minor groove binders 1998-2004. / Suckling, C.J.

In: Expert Opinion on Therapeutic Patents, Vol. 14, No. 12, 01.12.2004, p. 1693-1724.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Minor groove binders 1998-2004

AU - Suckling, C.J.

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Several classes of compounds, including heterocyclic polyamides, aryl benzimidazoles, pyrrolobenzodiazepines, amidino arylfurans and benzofurans, have been found to bind to the minor groove of DNA with sequence selectivity and potential therapeutic consequences. Many such compounds are synthetic analogues of natural products such as distamycin, netropsin, CC-1065, duocarmycin and anthramycin. Biological activity has been demonstrated in antibacterial, antifungal, antiviral and anticancer applications, and several compounds are in clinical trials. This review covers patents since 1998 and reviews the structures, mechanisms and biological activity of minor groove binders in the context of the current scientific understanding described in the journal literature.

AB - Several classes of compounds, including heterocyclic polyamides, aryl benzimidazoles, pyrrolobenzodiazepines, amidino arylfurans and benzofurans, have been found to bind to the minor groove of DNA with sequence selectivity and potential therapeutic consequences. Many such compounds are synthetic analogues of natural products such as distamycin, netropsin, CC-1065, duocarmycin and anthramycin. Biological activity has been demonstrated in antibacterial, antifungal, antiviral and anticancer applications, and several compounds are in clinical trials. This review covers patents since 1998 and reviews the structures, mechanisms and biological activity of minor groove binders in the context of the current scientific understanding described in the journal literature.

KW - antibacterial agent

KW - antifungal agent

KW - antiviral agent

KW - aryl benzimidazole

KW - cancer chemotherapy

KW - DNA binding compound

KW - heterocyclic polyamide

KW - minor groove

KW - natural product analogue

KW - pyrrolobenzodiazepine

UR - http://dx.doi.org/10.1517/13543776.14.12.1693

U2 - 10.1517/13543776.14.12.1693

DO - 10.1517/13543776.14.12.1693

M3 - Article

VL - 14

SP - 1693

EP - 1724

JO - Expert Opinion on Therapeutic Patents

T2 - Expert Opinion on Therapeutic Patents

JF - Expert Opinion on Therapeutic Patents

SN - 1354-3776

IS - 12

ER -